These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27714779)

  • 1. Pharmacological mechanisms underlying the cardiovascular effects of the "bath salt" constituent 3,4-methylenedioxypyrovalerone (MDPV).
    Schindler CW; Thorndike EB; Suzuki M; Rice KC; Baumann MH
    Br J Pharmacol; 2016 Dec; 173(24):3492-3501. PubMed ID: 27714779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV).
    Watterson LR; Kufahl PR; Nemirovsky NE; Sewalia K; Grabenauer M; Thomas BF; Marusich JA; Wegner S; Olive MF
    Addict Biol; 2014 Mar; 19(2):165-74. PubMed ID: 22784198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reinforcing effects of abused 'bath salts' constituents 3,4-methylenedioxypyrovalerone and α-pyrrolidinopentiophenone and their enantiomers.
    Gannon BM; Rice KC; Collins GT
    Behav Pharmacol; 2017 Oct; 28(7):578-581. PubMed ID: 28570297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of novel synthetic stimulants structurally related to the "bath salts" constituent 3,4-methylenedioxypyrovalerone (MDPV).
    Marusich JA; Antonazzo KR; Wiley JL; Blough BE; Partilla JS; Baumann MH
    Neuropharmacology; 2014 Dec; 87():206-13. PubMed ID: 24594476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular effects of 3,4-methylenedioxypyrovalerone (MDPV) in male and female Sprague-Dawley rats.
    McClenahan SJ; Hambuchen MD; Simecka CM; Gunnell MG; Berquist MD; Owens SM
    Drug Alcohol Depend; 2019 Feb; 195():140-147. PubMed ID: 30634109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditioned place preference following concurrent treatment with 3, 4-methylenedioxypyrovalerone (MDPV) and methamphetamine in male and female Sprague-Dawley rats.
    Risca HI; Zuarth-Gonzalez JD; Baker LE
    Pharmacol Biochem Behav; 2020 Nov; 198():173032. PubMed ID: 32888971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective Effects of Abused "Bath Salt" Constituent 3,4-Methylenedioxypyrovalerone in Mice: Drug Discrimination, Locomotor Activity, and Thermoregulation.
    Gannon BM; Williamson A; Suzuki M; Rice KC; Fantegrossi WE
    J Pharmacol Exp Ther; 2016 Mar; 356(3):615-23. PubMed ID: 26769917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and chronic neurobehavioral effects of the designer drug and bath salt constituent 3,4-methylenedioxypyrovalerone in the rat.
    Atehortua-Martinez LA; Masniere C; Campolongo P; Chasseigneaux S; Callebert J; Zwergel C; Mai A; Laplanche JL; Chen H; Etheve-Quelquejeu M; Mégarbane B; Benturquia N
    J Psychopharmacol; 2019 Mar; 33(3):392-405. PubMed ID: 30644332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3,4-Methylenedioxypyrovalerone: Neuropharmacological Impact of a Designer Stimulant of Abuse on Monoamine Transporters.
    Magee CP; German CL; Siripathane YH; Curtis PS; Anderson DJ; Wilkins DG; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2020 Aug; 374(2):273-282. PubMed ID: 32385092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of hypocretin/orexin receptor blockade on drug-taking and ultrasonic vocalizations (USVs) associated with low-effort self-administration of cathinone-derived 3,4-methylenedioxypyrovalerone (MDPV) in rats.
    Simmons SJ; Martorana R; Philogene-Khalid H; Tran FH; Gentile TA; Xu X; Su S; Rawls SM; Muschamp JW
    Psychopharmacology (Berl); 2017 Nov; 234(21):3207-3215. PubMed ID: 28786030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products.
    Baumann MH; Partilla JS; Lehner KR; Thorndike EB; Hoffman AF; Holy M; Rothman RB; Goldberg SR; Lupica CR; Sitte HH; Brandt SD; Tella SR; Cozzi NV; Schindler CW
    Neuropsychopharmacology; 2013 Mar; 38(4):552-62. PubMed ID: 23072836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reinforcing Effects of Binary Mixtures of Common Bath Salt Constituents: Studies with 3,4-Methylenedioxypyrovalerone (MDPV), 3,4-Methylenedioxymethcathinone (methylone), and Caffeine in Rats.
    Gannon BM; Galindo KI; Mesmin MP; Rice KC; Collins GT
    Neuropsychopharmacology; 2018 Mar; 43(4):761-769. PubMed ID: 28677665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and biological evaluation of a bi-specific vaccine against α-pyrrolidinovalerophenone (α-PVP) and 3,4-methylenedioxypyrovalerone (MDPV) in rats.
    McClenahan SJ; Kormos CM; Gunnell M; Hambuchen MD; Lamb P; Carroll FI; Lewin AH; Peterson EC; Owens SM
    Vaccine; 2020 Jan; 38(2):336-344. PubMed ID: 31629568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combination of MDPV and ethanol results in decreased cathinone and increased alcohol levels. Study of such pharmacological interaction.
    López-Arnau R; Buenrostro-Jáuregui M; Muñoz-Villegas P; Rodríguez-Morató J; Ciudad-Roberts A; Duart L; Camarasa J; De la Torre R; Pubill D; Escubedo E
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jun; 76():19-28. PubMed ID: 28219712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing rewarding and reinforcing properties between 'bath salt' 3,4-methylenedioxypyrovalerone (MDPV) and cocaine using ultrasonic vocalizations in rats.
    Simmons SJ; Gregg RA; Tran FH; Mo L; von Weltin E; Barker DJ; Gentile TA; Watterson LR; Rawls SM; Muschamp JW
    Addict Biol; 2018 Jan; 23(1):102-110. PubMed ID: 27910188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated exposure to 3,4-methylenedioxypyrovalerone and cocaine produces locomotor sensitization with minimal effects on brain monoamines.
    Kohler RJ; Perrine SA; Baker LE
    Neuropharmacology; 2018 May; 134(Pt A):22-27. PubMed ID: 29042316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of orally self-administered bath salt constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice.
    Gannon BM; Russell LN; Modi MS; Rice KC; Fantegrossi WE
    Drug Alcohol Depend; 2017 Oct; 179():408-415. PubMed ID: 28866386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamate carboxypeptidase II (GCPII) inhibitor 2-PMPA reduces rewarding effects of the synthetic cathinone MDPV in rats: a role for N-acetylaspartylglutamate (NAAG).
    Hicks C; Gregg RA; Nayak SU; Cannella LA; Schena GJ; Tallarida CS; Reitz AB; Smith GR; Rawls SM
    Psychopharmacology (Berl); 2017 Jun; 234(11):1671-1681. PubMed ID: 28251297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between reinforcement history and drug-primed reinstatement: Studies with MDPV and mixtures of MDPV and caffeine.
    Doyle MR; Sulima A; Rice KC; Collins GT
    Addict Biol; 2021 Mar; 26(2):e12904. PubMed ID: 32237282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitization to the locomotor stimulant effects of "bath salt" constituents, 4-methylmethcathinone (4-MMC) and 3,4-methylenedioxypyrovalerone (MDPV), in male Sprague-Dawley rats.
    Berquist MD; Traxler HK; Mahler AM; Baker LE
    Drug Alcohol Depend; 2016 Jul; 164():128-134. PubMed ID: 27181413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.